Join our mailing list
Get exclusive deals and learn about new products!
Reliable shipping
Flexible returns
Integrate molecular diagnostics and targeted therapies for personalized oncology practice
Cancer treatment is no longer one-size-fits-all. Molecular profiling, liquid biopsy, and AI-driven diagnostics now enable clinicians to match patients with therapies targeting their tumor's unique genetic signature. Advanced Diagnostic and Therapeutic Approaches for Precision Cancer Care: Integrating Modern Technologies for Improved Detection and Treatment Outcomes connects research advances with clinical applications. A team of oncology researchers examines liquid biopsy, biomarker-based diagnostics, immunotherapy, and nanotechnology-driven drug delivery to enable individualized treatment strategies.
This reference covers cancer biology fundamentals, disease progression mechanisms, and therapeutic resistance while detailing single-cell and multi-omics technologies, radiomics, radiogenomics, and RNA-based therapies. Explore artificial intelligence applications in diagnostic imaging, digital pathology for treatment decisions, and combination treatment protocols. Case studies demonstrate real-world applications of gene therapy, monoclonal antibodies, and personalized surgical interventions across multiple cancer types.
Readers will also find:
Designed for oncologists, cancer researchers, pathologists, radiologists, and advanced trainees, this reference provides the technical depth required for implementing precision medicine protocols. Whether developing personalized treatment plans or advancing translational research, Advanced Diagnostic and Therapeutic Approaches for Precision Cancer Care delivers authoritative guidance on diagnostic and therapeutic innovations shaping contemporary oncology practice.
Vibhav Gautam is an Assistant Professor at the Centre of Experimental Medicine and Surgery, Institute of Medical Sciences, Banaras Hindu University. His research integrates ethnopharmacology, nanobiotechnology, and omics sciences to address cancer, focusing on bioactive compounds from fungal endophytes and targeted nanomedicine-based drug delivery systems.
Brijesh Kumar is a cancer biology researcher specializing in breast cancer initiation, progression, and metastasis. He studies inter-individual variability in breast epithelial cell pliancy, molecular subtype genesis, and chemoresistance pathways using tumor models to develop improved therapeutic approaches.
Surya Pratap Singh, PhD, is an Assistant Professor at the Indian Institute of Technology Dharwad, leading the Integrated Biophotonics Lab. Following postdoctoral research at Stanford, MIT, and the University of Eastern Finland, his work focuses on Raman and fluorescence spectroscopy for biomedical diagnosis.
Nazar Hussain is an Assistant Professor of Medicinal Chemistry at the Institute of Medical Sciences, Banaras Hindu University. His research explores C-glycoside synthesis, palladium-catalyzed reactions, and total synthesis of natural products with applications in drug discovery.
| Publication Date: | 03 December 2026 |
| Publisher: | Wiley |
| Imprint: | Wiley |
| ISBN-13: | 9781394376445 |
| Format: | Hardback |